SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurocrine Biosciences (NBIX)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
1834 74 0 NBIX
Emcee:  Billy Dunn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1134Wilder This is a little bit of a mystery here. Neurocrine in their latest reporIcebrg-6/6/2003
1133Would keep gnrh proprietary, multiple indications, until late P3. Thank heavenskeokalani'nui-6/6/2003
1132Neurocrine has filed (what I believe is) a shelf registration to sell 200 mUSD wIcebrg-6/6/2003
1131>>Just trying to understand the pop yesterday>> At this time of theIcebrg-6/6/2003
1130Erik, The abstracts that were posted on NBIX's website did not look to me toquidditch-6/6/2003
1129Takeda Tries to Counter Concern for New Sleeping Pill Message 19008144Icebrg-6/6/2003
1128His holding (I and D) increased from last filing, so he probably exercised few Miljenko Zuanic-5/29/2003
1127>> Lyons sells 10000 at $50>> A sensible move. He still has 691.000Icebrg-5/29/2003
1126Lyons sells 10000 at $50. Follows two additional 50k sales by nbix insiders, a keokalani'nui-5/29/2003
1125Harry, Few days ago I was looking at Medline and found that withdrawal/rebound Miljenko Zuanic-5/20/2003
1124Miljenko: So far as I know, rebound insomnia--which by definition is worse thaNeuroInvestment-5/20/2003
1123Probably Harry T. (NI) will have more to say, but is two days sufficient to declMiljenko Zuanic-5/19/2003
1122Neurocrine Reports Additional Positive Results From Phase III Chronic Insomnia Tquidditch-5/19/2003
1121Endocrinology Vol. 144, No. 6 2580-2587 Copyright © 2003 by The Endocrine SMiljenko Zuanic-5/14/2003
1120Endocrinology Vol. 144, No. 6 2396-2403 Copyright © 2003 by The Endocrine SMiljenko Zuanic-5/14/2003
1119Probably! [eom]Miljenko Zuanic-5/13/2003
1118GnRh Backup? J Med Chem 2003 Apr 24;46(9):1769-72 Related Articles, Links keokalani'nui-5/13/2003
1117SSB take on q: Neurocrine Biosciences (NBIX) First Quarter Financial Results; mopgcw-4/30/2003
1116Briefing: (I assume the discrepancy between actual and forecast revenues has to tom pope-4/29/2003
1115>>SAN DIEGO, April 29 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Intuck-4/29/2003
1114<i>Of course, with PHA to digest in the meanwhile, PFE probably won't keokalani'nui-4/29/2003
1113Speculation (shrewdly-informed variety) about potential munch of NBIX by PFE: MRCMac-4/28/2003
1112NBI-6024 for Type I diabetes In their recently released Annual Report NeurocrinIcebrg-4/27/2003
1111"Sometimes I wonder if the whole problem comes back to overdosing on my aTorben Noerup Nielsen-4/22/2003
1110I chatted with a physician at a sleep clinic, but he wasn't alarmed that my Mike McFarland-4/22/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News